NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
Closed Special Notice Posted
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice is published by the National Cancer Institute (NCI) regarding a subcontract opportunity at the Frederick National Laboratory for Cancer Research (FNLCR), a government-owned, contractor-operated Federally Funded Research and Development Center (FFRDC) currently operated by Leidos Biomedical Research, Inc. for the NCI. The Notice is for informational purposes only and is not a formal solicitation.
The purpose of this Special Notice is to publicize the requirement for a contractor to provide labor, materials, supervision, and equipment for the remediation and refurbishment of Building 1073 at the FNLCR facility in Fort Detrick, Maryland. The response deadline is May 1, 2024 at 3:00 pm, and a pre-bid conference and site visits on April 9 and April 15, 2024 are mandatory. All technical and business questions are due by April 18, 2024. The point of contact for the solicitation is Traci Parlett-Leaman. The FNLCR partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS.
Notice text
This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR).
The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR.
The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.
Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
Description of Work: Contractor shall furnish all labor, materials, supervision, and equipment for the Remediation and Refurbishment in Building 1073 in accordance with the Technical Specifications and Drawings in Section J.
The performance of work will be performed at the Frederick National Laboratory for Cancer Research (FNLCR)on Fort Detrick, Frederick MD.
Pre-bid Conference and Site Visit: A pre-bid conference and site visit will be held on Tuesday, April 9, 2024, at 1:00 pm in Building 350 Beasley Drive Conference Room B. An additional site visit will be held on Monday, April 15, 2024, at 10:00 am in Building 350 Beasley Drive Conference Room B. Attendance at one of the site visits is mandatory (see Section L.5 for additional details). The contractor must acknowledge that is has taken steps reasonably necessary to ascertain the nature and location of the work which can affect the work and cost as described in FAR 52.236-3 and Leidos Biomed will not be responsible for any differing site conditions. Please contact the party in Block 9 with your intention to attend. All technical and business-related questions are due by Thursday, April 18, 2024, by 3:00 pm.
Leidos Biomedical Research, Inc. Point of Contact for a copy of Solicitation/RFP No: H24-2526: Traci Parlett-Leaman, at traci.leaman@nih.gov
Files
| File | Type | Posted |
|---|---|---|
| H24-2526 SAM Special Notice.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research” | National Cancer Institute | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity